Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TANFAC Industries Ltd. Capital/Financing Update 2024

Oct 6, 2024

61879_rns_2024-10-06_bed12e6b-9a1e-46fc-b75e-7215843f1a98.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

PRESS & MEDIA RELEASE

OCTOBER 7, 2024

==> picture [60 x 51] intentionally omitted <==

We refer to our communication dated 10[th] February 2023 on the proposed brownfield expansion of our Hydrofluoric Acid capacity in its existing unit from 14,850 MT to 29,700 MT to be implemented in 15 to 18 months from the date of announcement.

We wish to inform you that the Company has completed the expansion project and commissioned the expanded capacity on 7[th] October 2024.

Speaking on the occasion, K. Sendhil Naathan, Managing Director of Tanfac Industries, said,

We are excited to announce that we have completed the expansion project at the cost of around ₹ 100 crores and commissioned the new State of the art HF plant as planned. With this TANFAC site has become one of the largest HF plants in India. In line with earlier communication, we intend to use majority of HF to manufacture high-end specialty fluoride molecules within our group companies. This expansion will sustain our growth trajectory going forward .”

Please find below the details required under Regulation 30 of Listing Regulations.

Sl. No. Particulars Disclosures
1. Existing capacity before
expansion
45 MT per day (14,850 MT per annum)
2. Revised capacity after
expansion
90 MT per day (29,700 MT per annum)
3. Implementation period 17 months
4. Total investment Around ₹ 100 crores

Contact Us

Contact Us
N R Ravichandaran
Chief Financial Officer
Ravichandran
Digitally signed by
Ravichandran N R
Tanfac Industries Limited N R
Date: 2024.10.06 22:45:59
+05'30'

Safe Harbour

This This document which have been prepared by Tanfac Industries Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever.

This document has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Document. This Document may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Document is expressly excluded.

01